Leithäuser F, Bäuerle M, Huynh M Q, Möller P
Department of Pathology, University of Ulm, Germany.
Blood. 2001 Nov 1;98(9):2762-70. doi: 10.1182/blood.v98.9.2762.
Primary mediastinal B-cell lymphoma (PMBL) is a subentity of diffuse large B-cell lymphoma with characteristic clinical, histomorphologic, immunophenotypical, and genetic features. Unlike other B-cell lymphomas, PMBL has not yet been the subject of comprehensive molecular studies on the rearranged immunoglobulin (Ig) gene. Such investigations have proved essential to obtaining information about the differentiation stage of the lymphomagenic B cell. In the present study, the clonally rearranged immunoglobulin heavy-chain gene of 13 PMBL cases is analyzed by polymerase chain reaction (PCR) in conjunction with cloning and DNA sequencing. Twelve of 13 rearrangements were potentially functional. All clonally rearranged immunoglobulin genes bore a high load of somatic mutations (average, 13.0%), which appeared to be selected for a functional antibody in the majority of cases. The comparison of cloned PCR products revealed no evidence of ongoing mutation of the immunoglobulin variable gene. By means of reverse-transcriptase PCR, lymphoma-specific immunoglobulin transcripts were detected in 8 of 13 cases, all of which were of the postswitched type, whereas immunoglobulin protein expression was undetectable except for 1 case. A PMBL cell line, MedB-1, generated from an IgG(-) parental tumor, constitutively expressed IgG protein in a subset of cells, which was moderately suppressed by interleukin-4 and up-regulated in the presence of dexamethasone. PMBL is thus characterized by a heavily mutated, class-switched immunoglobulin gene without evidence of ongoing mutational activity. Moreover, our data indirectly suggest that regulation by extrinsic signals contributes to the immunoglobulin-negative phenotype of PMBL.
原发性纵隔B细胞淋巴瘤(PMBL)是弥漫性大B细胞淋巴瘤的一个亚型,具有独特的临床、组织形态学、免疫表型和遗传学特征。与其他B细胞淋巴瘤不同,PMBL尚未成为关于重排免疫球蛋白(Ig)基因的全面分子研究的对象。事实证明,此类研究对于获取有关致瘤性B细胞分化阶段的信息至关重要。在本研究中,采用聚合酶链反应(PCR)结合克隆和DNA测序分析了13例PMBL病例的克隆性重排免疫球蛋白重链基因。13个重排中有12个可能具有功能。所有克隆性重排的免疫球蛋白基因都有高负荷的体细胞突变(平均为13.0%),在大多数情况下,这些突变似乎是为功能性抗体而选择的。对克隆的PCR产物进行比较,未发现免疫球蛋白可变基因有正在发生突变的证据。通过逆转录酶PCR,在13例病例中的8例检测到淋巴瘤特异性免疫球蛋白转录本,所有这些转录本均为转换后类型,而除1例病例外未检测到免疫球蛋白蛋白表达。从IgG(-)亲本肿瘤产生的PMBL细胞系MedB-1在一部分细胞中组成性表达IgG蛋白,该表达受到白细胞介素-4的适度抑制,并在存在地塞米松的情况下上调。因此,PMBL的特征是免疫球蛋白基因发生高度突变且已发生类别转换,没有正在进行突变活动的证据。此外,我们的数据间接表明,外在信号的调节有助于PMBL的免疫球蛋白阴性表型。